Innoventric
PrivateLast Round
Series B
Oct 29, 2024
Total Funding Raised
$42.5M
Company Overview
Innoventric is a medical device company specializing in percutaneous solutions for the treatment of tricuspid regurgitation, offering a functional valve replacement that features Cross-Caval anchoring and a unique multi-valve design to enhance blood flow regulation and improve patient outcomes.
Sector
Mobility, Transportation & Logistics
Verticals
Customer Experience, Autonomous Vehicles
Business Model
B2B
Customer Profile
Hardware Sales, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Innoventric Comps
Public and private peers based on sector, stage, and business model.
Innoventric Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Oct 29, 2024 | ||||
| Series A | Nov 1, 2021 |
Innoventric Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| European Innovation Council Fund | Series A |
| RA Capital Management | Series B |
| BRM Group | Seed, Series A, Series B |
| Mivtach Shamir Holdings | Series B, Seed, Series A |
| JG Investment | Series B |
Innoventric Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Innoventric's valuation, stock price, and market status.
